Figure 1
From: Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
Diagrammatic representation of the HDAC3-SMARCA4-miR-27a-PAX3::FOXO1 circuit, which can be disrupted by entinostat or SMARCA4 bromodomain activity inhibitor, PFI-3. Adapted from 3.
